Pegaptanib Sodium

CAS 343621-12-9 1 FDA-DMF supplierNucleotide

Overview

Pegaptanib Sodium is an anti-angiogenic medicine used in the treatment of neovascular (wet) age-related macular degeneration. It works by inhibiting the activity of vascular endothelial growth factor (VEGF).

Therapeutic areas

Ophthalmology

Related APIs

Levofloxacin
27 suppliers
Latanoprost
22 suppliers
Bimatoprost
15 suppliers
Travoprost
15 suppliers
Timolol Maleate
13 suppliers
Brimonidine Tartrate
11 suppliers
Acetazolamide
11 suppliers
Clonidine Hydrochloride
10 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo